Fisher Marc, Henninger Nils
Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Curr Neurol Neurosci Rep. 2007 Jan;7(1):35-41. doi: 10.1007/s11910-007-0019-1.
Many advances have occurred regarding an increased understanding of the basic pathophysiology of ischemic brain injury that could lead to enhanced therapy for this disorder. Among the more important basic science advances are enhanced knowledge of the components of the ischemic cascade, the phenomenon of ischemic preconditioning, the potential relevance of hibernation, studies on gene expression in ischemic tissue, and imaging identification of the ischemic penumbra. The large number of unsuccessful prior clinical trials with a wide range of purported acute stroke therapies has provided many insights and lessons regarding how to perform better trials in the future. Translating these basic science and clinical trial design advances into effective and safe therapies will require increased interaction and cooperation between basic scientists and clinical researchers.
在对缺血性脑损伤基本病理生理学的认识不断加深方面已经取得了许多进展,这可能会带来针对该疾病的更有效治疗方法。在更重要的基础科学进展中,包括对缺血级联反应组成部分的深入了解、缺血预处理现象、冬眠的潜在相关性、缺血组织中基因表达的研究以及缺血半暗带的影像学识别。此前大量针对各种所谓急性中风疗法的临床试验均未成功,这为未来如何开展更好的试验提供了许多见解和经验教训。将这些基础科学和临床试验设计的进展转化为有效且安全的治疗方法,需要基础科学家和临床研究人员之间加强互动与合作。